Leuthold Group, LLC Bristol Myers Squibb CO Transaction History

Leuthold Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$65.71 - $74.53 $19,384 - $21,986	-295 Reduced 5.41%	5,162 $357,000
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $5,478 - $6,487	-80 Reduced 1.44%	5,457 $393,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $402,096 - $442,849	5,537 New	5,537 $426,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $410,184 - $464,814	-7,104 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $11,371 - $12,600	-198 Reduced 2.71%	7,104 $428,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $15,678 - $18,329	-286 Reduced 3.77%	7,302 $429,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $32,665 - $47,470	-704 Reduced 8.49%	7,588 $423,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $408,049 - $532,263	8,292 New	8,292 $532,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.